A/Prof. Michelle Hill
Associate Professor Michelle Hill heads the Cancer Proteomics Group at the University of Queensland Diamantina Institute (UQDI), Brisbane, and is the Academic Lead of the Proteomics & Mass Spectrometry Core Facility of the Translational Research Institute (TRI), in which UQDI is housed. Dr Hill is an elected member of UQ’s Academic Board, and the international Human Proteome Organisation (HUPO) Council.
Michelle obtained her PhD investigating insulin signalling using phosphoproteomics with Prof David James at the University of Queensland. She undertook two postdoctoral positions in Switzerland and Ireland before returning Brisbane. In 2009 she established the Cancer Proteomics Group at UQDI. In addition to the development and translation of new clinical tests, the team also works on dissecting the link between metabolism and cancer. Current research focus is on the role of cholesterol-rich membrane microdomains on cancer development and progression, with extracellular vesicles being a potential mechanism.